CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
30.40 0.04(0.13%) NAV as on 08 May 2024
-1.59 % 1 M
55.1 % 1 Y
16.24 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.96

As on 31 Mar, 2024
age-icon Age :

5 yrs 9 m

Since 13 07 ,2018
exit_load Exit Load :

1%

aum AUM :

3,772.32 Crs

lock_in Lock-in :

1% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

6.22

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

S&P BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dharmesh Kakkad

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2024
Others 1.30 %
Equity 98.70 %

TOP HOLDINGS

Sun Pharmaceutical Industries...15.24 %
Dr. Reddy's Laboratories Ltd.7.19 %
Divi's Laboratories Ltd.6.68 %
Aurobindo Pharma Ltd.6.56 %
Apollo Hospitals Enterprise Ltd.6.45 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs71.58
Hospital & Healthcare Services16.91
Insurance4.38
Chemicals3.28
Business Support1.78
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)9.5417.3519.6918.6430.20
Net Assets(Rs Crores) (as on 31-Mar-2024) 1073.47 2213.63 2500.42 2594.59 3772.32
Scheme Returns(%)(Absolute)-6.3883.7912.51-5.3861.15
B'mark Returns(%)(Absolute)NANANANANA
Category Rank15/7519/7547/7563/7612/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity30.400.04(0.13%)NAV As on 08 May, 202413-Jul-2018Inception Date3,772.32AUM In Cr.55.10%1Y16.24%3Y25.00%5Y21.03%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity343.94-6.11(-1.75%)NAV As on 08 May, 202414-Jul-1999Inception Date2,667.21AUM In Cr.51.80%1Y16.32%3Y23.45%5Y16.08%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.30-0.47(-1.43%)NAV As on 08 May, 202430-Nov-2018Inception Date2,352.32AUM In Cr.49.58%1Y15.89%3Y25.95%5Y24.06%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity25.12-0.50(-1.94%)NAV As on 08 May, 202428-Dec-2015Inception Date893.64AUM In Cr.52.43%1Y15.53%3Y22.62%5Y11.64%Since Inception
Nippon India Pharma Fund(G)Very HighEquity425.630.03(0.01%)NAV As on 08 May, 202405-Jun-2004Inception Date7,132.82AUM In Cr.49.60%1Y14.34%3Y23.41%5Y20.70%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity30.95-0.61(-1.92%)NAV As on 08 May, 202402-Jul-2018Inception Date2,235.15AUM In Cr.46.77%1Y13.97%3Y24.09%5Y21.30%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.